🇩🇰 Denmark Country × Condition
melanoma Clinical Trials in Denmark
Active clinical trials for melanoma with research sites in Denmark. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇰 Denmark
Active Trials in Denmark (3)
NCT05899465 Phase 3
Recruiting
Perioperative Treatment With Tranexamic Acid in Melanoma
Enrollment
1,204 pts
Country
🇩🇰 Denmark
University of Aarhus
View Trial → NCT04752826 Phase 1, Phase 2
Recruiting
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Enrollment
176 pts
Country
🇩🇰 Denmark
BioInvent International AB
View Trial → NCT05280314 Phase 2
Recruiting
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Enrollment
60 pts
Country
🇩🇰 Denmark
IO Biotech
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in Denmark?
There are currently 3 active clinical trials for melanoma with sites in Denmark, of which 3 are actively recruiting patients.
How can I join a melanoma clinical trial in Denmark?
To join a melanoma clinical trial in Denmark, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Denmark directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in Denmark?
Active melanoma trials in Denmark span Phase 3, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology